ArticleThe pharmacogenomics journal2019

An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care.

Reinier L Sluiter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.